The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: A systematic review and Meta-analysis [report]

Yushuai Yu, Jie Zhang, Kaiyan Huang, Yuxiang Lin, Chuangui Song
2021 unpublished
Review question / Objective: We conducted this meta-analysis to explore the efficacy and safety of Tyrosine kinase inhibitors (TKIs) compared with non-TKIs regimens in HER-2 positive breast cancer with brain metastases. Condition being studied: The survival of breast cancer brain metastasis (BCBM) patients is extremely poor. The cornerstone INPLASY 1 International Platform of Registered Systematic Review and Meta-analysis Protocols
doi:10.37766/inplasy2021.7.0064 fatcat:wdzppmlhkbfntnqkkhrznfwbsu